shc-1 acts in the IIS pathway for the control of life span and stress response. (A) daf-16(RNAi) does not reduce shc-1 mutant life span. Wild type on pL4440: 15.4 ± 0.4 d (n = 99); shc-1(ok198) on pL4440: 10.8 ± 0.3 d (n = 90, P < 0.0001); daf-16(RNAi): 10.1 ± 0.2 d (n = 100, P < 0.0001); shc-1(ok198); daf-16(RNAi): 10.1 ± 0.3 d [n = 82, P = 0.6713 vs. daf-16(RNAi)]. (B) Life-span analysis of daf-16(mgDf50) and shc-1(ok198). The assays were performed in a fer-15(b26) background at 25°C to prevent progeny. shc-1(ok198); fer-15(b26): 10.5 ± 0.2 d (n = 160, P < 0.0001); fer-15(b26): 14.0 ± 0.2 d (n = 160); daf-16(mgDf50); fer-15(b26): 10.1 ± 0.2 d (n = 107, P < 0.0001); daf-16(mgDf50) shc-1(ok198); fer-15(b26): 10.2 ± 0.3 d (n = 104, P < 0.0001). (C) Overexpression of daf-16 partially suppresses the shc-1 mutant life span. shc-1(ok198): 8.8 ± 0.3 d (n = 70); wild type: 14.4 ± 0.1 d (n = 204); Is[daf-16∷gfp]: 15.8 ± 0.5 d (n = 139, P = 0.0437); shc-1(ok198); Is[daf-16∷gfp]: 11.1 ± 0.4 d (n = 90, P < 0.0001). (D) age-1(hx546) suppresses the shc-1(ok198) aging phenotype. Wild type: 14.2 ± 0.4 d (n = 204); shc-1 (ok198): 8.4 ± 0.3 d (n = 152, P < 0.0001); shc-1(ok198); age-1(hx546): 17.5 ± 0.5 d (n = 178, P < 0.0001); age-1(hx546): 17.6 ± 0.5 d (n = 245, P < 0.0001). (E) daf-2(e1368) extends the short life span of shc-1(ok198). Wild type: 14.3 ± 0.35 d (n = 104); shc-1 (ok198): 10.6 ± 0.3 d (n = 103, P < 0.0001); daf-2(e1368): 25.3 ± 0.6 d (n = 110, P < 0.0001); shc-1(ok198); daf-2(e1368): 20.2 ± 0.6 d (n = 109, P < 0.0001). (F) Effect of daf-2(e1370), daf-16(m26), and age-1(hx546) on the oxidative stress sensitivity of shc-1(ok198). Animals were exposed to 200 mM and 100 mM paraquat, respectively. All data are listed as mean survival ± standard error of the mean, n = 100 per each strain. Data were combined from at least two independent experiments. (G) daf-2(e1370) increases the life span of shc-1(ok198). The assay was performed in a fer-15(b26) background at 25°C to prevent progeny. fer-15(b26): 13.0 ± 0.2 d (n = 217); shc-1(ok198); fer-15(b26): 10.7 ± 0.2 d (n = 216, P < 0.0001 vs. fer-15); fer-15(b26); daf-2(e1370): 31.8 ± 0.9 d (n = 160, P < 0.0001 vs. fer-15); shc-1(ok198); fer-15(b26); daf-2(e1370): 27.2 ± 0.6 d (n = 210, P < 0.0001 vs. fer-15). (H) The accelerated rate of lipofuscin accumulation in shc-1(ok198) is suppressed by daf-2(e1370). Quantification of the gut autofluorescence of fer-15(b26), shc-1(ok198); fer-15(b26), fer-15(b26); daf-2(e1370), and shc-1(ok198); fer-15(b26); daf-2(e1370) at day 10. Error bars represent the standard error of the mean. (***) P < 0.0001 comparing shc-1 with the shc-1; daf-2 mutant. (I) SHC-1 interacts with DAF-2 in HEK 293T cells. Membrane-bound sIg7-tagged DAF-2 (sIg.7.DAF-2) or control proteins (sIg7-tag and sIg7.control protein) were coexpressed with Flag-tagged SHC-1 (F.SHC-1) in HEK 293T cells and precipitated with Protein G Sepharose. (Top) Western blot analysis was performed with anti-Flag antibody. (Bottom) Expression levels of all proteins in the lysates and precipitates are shown.